Kristen Kluska's Stock Ratings

Cantor Fitzgerald Analyst

Kristen Kluska is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

44.0%

Smart Score

78.5%

Overall Average Return Percentile

93rd

Number of Ratings

111
Buy NowGet Alert
05/20/2024FULCBuy Now
Fulcrum Therapeutics
$7.70198.7% → $23Initiates → OverweightGet Alert
05/17/2024ETNBBuy Now
89bio
$8.94224.38% → $29ReiteratesOverweight → OverweightGet Alert
05/16/2024ABEOBuy Now
Abeona Therapeutics
$4.45371.91%$28 → $21MaintainsOverweightGet Alert
05/16/2024MREOBuy Now
Mereo BioPharma Group
$3.32110.84% → $7ReiteratesOverweight → OverweightGet Alert
05/15/2024IRONBuy Now
Disc Medicine
$32.37162.59% → $85ReiteratesOverweight → OverweightGet Alert
05/15/2024TSHABuy Now
Taysha Gene Therapies
$3.09126.54% → $7ReiteratesOverweight → OverweightGet Alert
05/14/2024CAPRBuy Now
Capricor Therapeutics
$6.3026.98% → $8ReiteratesOverweight → OverweightGet Alert
05/10/2024ADMABuy Now
ADMA Biologics
$9.426.16%$8 → $10MaintainsOverweightGet Alert
05/03/2024RAREBuy Now
Ultragenyx Pharmaceutical
$40.64163.29% → $107ReiteratesOverweight → OverweightGet Alert
05/02/2024SRPTBuy Now
Sarepta Therapeutics
$130.83-2.16% → $128ReiteratesNeutral → NeutralGet Alert
04/30/2024TSHABuy Now
Taysha Gene Therapies
$3.09126.54% → $7ReiteratesOverweight → OverweightGet Alert
04/30/2024ATNMBuy Now
Actinium Pharma
—— → $21ReiteratesOverweight → OverweightGet Alert
04/23/2024ABEOBuy Now
Abeona Therapeutics
$4.45708.99% → $36ReiteratesOverweight → OverweightGet Alert
04/19/2024TSHABuy Now
Taysha Gene Therapies
$3.09126.54% → $7ReiteratesOverweight → OverweightGet Alert
04/18/2024TSHABuy Now
Taysha Gene Therapies
$3.09126.54% → $7ReiteratesOverweight → OverweightGet Alert
04/12/2024PTCTBuy Now
PTC Therapeutics
$39.9912.53% → $45ReiteratesOverweight → OverweightGet Alert
04/05/2024ETNBBuy Now
89bio
$8.94224.38% → $29ReiteratesOverweight → OverweightGet Alert
04/05/2024RAREBuy Now
Ultragenyx Pharmaceutical
$40.64163.29% → $107ReiteratesOverweight → OverweightGet Alert
04/01/2024HUMABuy Now
Humacyte
$7.10-1.4% → $7ReiteratesOverweight → OverweightGet Alert
04/01/2024ATNMBuy Now
Actinium Pharma
—— → $21ReiteratesOverweight → OverweightGet Alert
03/28/2024MREOBuy Now
Mereo BioPharma Group
$3.32110.84% → $7ReiteratesOverweight → OverweightGet Alert
03/22/2024MREOBuy Now
Mereo BioPharma Group
$3.32110.84% → $7ReiteratesOverweight → OverweightGet Alert
03/22/2024CLDXBuy Now
Celldex Therapeutics
$37.7577.48% → $67ReiteratesOverweight → OverweightGet Alert
03/20/2024TSHABuy Now
Taysha Gene Therapies
$3.09126.54% → $7ReiteratesOverweight → OverweightGet Alert
03/06/2024RIGLBuy Now
Rigel Pharmaceuticals
$0.97209.92%$2 → $3MaintainsNeutralGet Alert
03/04/2024ETNBBuy Now
89bio
$8.94224.38% → $29ReiteratesOverweight → OverweightGet Alert
03/01/2024PTCTBuy Now
PTC Therapeutics
$39.9912.53% → $45ReiteratesOverweight → OverweightGet Alert
02/29/2024ADMABuy Now
ADMA Biologics
$9.42-15.07%$6.5 → $8MaintainsOverweightGet Alert
02/29/2024FOLDBuy Now
Amicus Therapeutics
$9.75125.64% → $22ReiteratesOverweight → OverweightGet Alert
02/29/2024SRPTBuy Now
Sarepta Therapeutics
$130.83-2.16% → $128ReiteratesNeutral → NeutralGet Alert